Last reviewed · How we verify
Standard of Care FIX Replacement therapy — Competitive Intelligence Brief
phase 3
Fix replacement therapy
Fix protein
Hemophilia
Small molecule
Live · refreshed every 30 min
Target snapshot
Standard of Care FIX Replacement therapy (Standard of Care FIX Replacement therapy) — Pfizer. Fix replacement therapy involves replacing the deficient or missing fix protein in the body.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Standard of Care FIX Replacement therapy TARGET | Standard of Care FIX Replacement therapy | Pfizer | phase 3 | Fix replacement therapy | Fix protein |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Fix replacement therapy class)
- Pfizer · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Standard of Care FIX Replacement therapy CI watch — RSS
- Standard of Care FIX Replacement therapy CI watch — Atom
- Standard of Care FIX Replacement therapy CI watch — JSON
- Standard of Care FIX Replacement therapy alone — RSS
- Whole Fix replacement therapy class — RSS
Cite this brief
Drug Landscape (2026). Standard of Care FIX Replacement therapy — Competitive Intelligence Brief. https://druglandscape.com/ci/standard-of-care-fix-replacement-therapy. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab